| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 3.84e-05 | 12 | 114 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 7.84e-05 | 15 | 114 | 3 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 1.16e-04 | 17 | 114 | 3 | GO:0009881 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TBX15 PAPPA2 FOXN1 BAK1 PTK2 HOXA3 TGFB3 TBX18 DLC1 CSF3R PTPRM NFIB GLI3 SEC24B ARID5B PRKCB PLAU SEMA6A KLK5 MYO15A | 1.48e-05 | 1269 | 112 | 20 | GO:0009887 |
| Domain | - | 4.14e-06 | 6 | 112 | 3 | 2.140.10.30 | |
| Domain | DPPIV_N | 4.14e-06 | 6 | 112 | 3 | PF00930 | |
| Domain | Peptidase_S9B_N | 4.14e-06 | 6 | 112 | 3 | IPR002469 | |
| Domain | Peptidase_S9 | 3.34e-05 | 11 | 112 | 3 | PF00326 | |
| Domain | Peptidase_S9 | 3.34e-05 | 11 | 112 | 3 | IPR001375 | |
| Domain | Opsin_red/grn | 1.07e-04 | 3 | 112 | 2 | IPR000378 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 12662155 | ||
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 1.41e-07 | 4 | 115 | 3 | 29386880 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 11476574 | ||
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 3.50e-07 | 5 | 115 | 3 | 2937147 | |
| Pubmed | Mouse and zebrafish Hoxa3 orthologues have nonequivalent in vivo protein function. | 6.99e-07 | 6 | 115 | 3 | 20498049 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 15581866 | ||
| Pubmed | 5.21e-06 | 486 | 115 | 10 | 20936779 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 15680353 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C CPAMD8 FRYL GALNT18 PTK2 HPS3 SH3BP4 DPP9 GRTP1 ZNF608 NFIB NUP210 ARID5B EHMT1 SEMA6A OLFM2 TMEM181 | 8.18e-06 | 1489 | 115 | 17 | 28611215 |
| Pubmed | Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. | 9.83e-06 | 13 | 115 | 3 | 12070080 | |
| Pubmed | EphB-ephrin-B2 interactions are required for thymus migration during organogenesis. | 9.83e-06 | 13 | 115 | 3 | 20616004 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23519473 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33932609 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28402104 | ||
| Pubmed | Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. | 1.08e-05 | 2 | 115 | 2 | 26242871 | |
| Pubmed | Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. | 1.08e-05 | 2 | 115 | 2 | 22736146 | |
| Pubmed | Defective colour vision associated with a missense mutation in the human green visual pigment gene. | 1.08e-05 | 2 | 115 | 2 | 1302020 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10319869 | ||
| Pubmed | Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. | 1.08e-05 | 2 | 115 | 2 | 12534281 | |
| Pubmed | Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3. | 1.08e-05 | 2 | 115 | 2 | 22760257 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23143267 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11369769 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21711053 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 38458339 | ||
| Pubmed | [Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer]. | 1.08e-05 | 2 | 115 | 2 | 21868344 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21969587 | ||
| Pubmed | DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. | 1.08e-05 | 2 | 115 | 2 | 16700509 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32986180 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11335122 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25464020 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32998073 | ||
| Pubmed | Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. | 1.08e-05 | 2 | 115 | 2 | 33896830 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7636184 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19581630 | ||
| Pubmed | Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation. | 1.08e-05 | 2 | 115 | 2 | 23079702 | |
| Pubmed | 1.25e-05 | 14 | 115 | 3 | 17382312 | ||
| Pubmed | Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. | 1.56e-05 | 15 | 115 | 3 | 16530750 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15866709 | ||
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 3.24e-05 | 3 | 115 | 2 | 21224225 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 3.24e-05 | 3 | 115 | 2 | 36216501 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15961541 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 29693275 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 34111401 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28755662 | ||
| Pubmed | Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. | 3.24e-05 | 3 | 115 | 2 | 11909944 | |
| Pubmed | DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation. | 3.24e-05 | 3 | 115 | 2 | 31525884 | |
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 3.24e-05 | 3 | 115 | 2 | 28751656 | |
| Pubmed | Structural and biochemical mechanisms of NLRP1 inhibition by DPP9. | 3.24e-05 | 3 | 115 | 2 | 33731929 | |
| Pubmed | DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation. | 3.24e-05 | 3 | 115 | 2 | 33731932 | |
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 3.24e-05 | 3 | 115 | 2 | 11545071 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23687340 | ||
| Pubmed | The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. | 3.24e-05 | 3 | 115 | 2 | 22266274 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 16704418 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25486458 | ||
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 3.24e-05 | 3 | 115 | 2 | 12511072 | |
| Pubmed | Molecular determinants of human red/green color discrimination. | 3.24e-05 | 3 | 115 | 2 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 3.24e-05 | 3 | 115 | 2 | 20579627 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 3.24e-05 | 3 | 115 | 2 | 23350963 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25380825 | ||
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 3.24e-05 | 3 | 115 | 2 | 20471354 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15560761 | ||
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 3.24e-05 | 3 | 115 | 2 | 10567724 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 14500905 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23608773 | ||
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 3.24e-05 | 3 | 115 | 2 | 31469404 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 18641303 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 20018851 | ||
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 3.24e-05 | 3 | 115 | 2 | 9238068 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 3.24e-05 | 3 | 115 | 2 | 17379811 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24072711 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 7958444 | ||
| Pubmed | 3.28e-05 | 19 | 115 | 3 | 2377456 | ||
| Pubmed | 3.28e-05 | 19 | 115 | 3 | 24315451 | ||
| Pubmed | 3.28e-05 | 19 | 115 | 3 | 25249461 | ||
| Pubmed | 5.94e-05 | 23 | 115 | 3 | 26965927 | ||
| Pubmed | 6.47e-05 | 653 | 115 | 10 | 22586326 | ||
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 6.48e-05 | 4 | 115 | 2 | 20043068 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 28103478 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 9620592 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 3303660 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 19091974 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 21862553 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 26438865 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 17249565 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 38060327 | ||
| Pubmed | Contribution of M-opsin-based color vision to refractive development in mice. | 6.48e-05 | 4 | 115 | 2 | 34126082 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 21203493 | ||
| Pubmed | Apoptotic dysregulation mediates stem cell competition and tissue regeneration. | 6.48e-05 | 4 | 115 | 2 | 37985759 | |
| Pubmed | Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells. | 6.48e-05 | 4 | 115 | 2 | 12167592 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 31461375 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 20832395 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 8088841 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 31846668 | ||
| Pubmed | Gcm2 regulates the maintenance of parathyroid cells in adult mice. | 6.48e-05 | 4 | 115 | 2 | 30677043 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 29396289 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 18713835 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16567464 | ||
| Pubmed | S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant. | 6.48e-05 | 4 | 115 | 2 | 24801621 | |
| Pubmed | CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. | 6.48e-05 | 4 | 115 | 2 | 20463654 | |
| GeneFamily | CD molecules|DASH family | 2.67e-06 | 7 | 78 | 3 | 1205 | |
| GeneFamily | Opsin receptors | 1.24e-05 | 11 | 78 | 3 | 215 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.31e-03 | 50 | 78 | 3 | 1293 | |
| GeneFamily | AT-rich interaction domain containing | 1.86e-03 | 15 | 78 | 2 | 418 | |
| GeneFamily | T-boxes | 2.69e-03 | 18 | 78 | 2 | 766 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | TBX15 CACNA1C LAPTM4A PGGHG TSC22D3 IRF1 ACTN1 ITGA1 GALNT18 TGFB3 TBX18 PIEZO2 FRMD6 PTPRM ARID5B PRKCB PLCL1 PDE7B | 6.61e-09 | 795 | 111 | 18 | M39050 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 3.29e-07 | 155 | 111 | 8 | M39246 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 9.02e-07 | 177 | 111 | 8 | M39245 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 7.04e-06 | 166 | 111 | 7 | M9015 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | CACNA1C C2orf69 ABCA2 IMPDH1 RBM4B KIAA0319 NFIB CELF3 PRKCB ZNF614 ACAP3 | 7.39e-06 | 488 | 111 | 11 | M39104 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CPAMD8 PGBD1 ITGA1 DLC1 CSF3R FRMD6 PTPRM GLI3 SCN7A PLAU PDE7B | 1.02e-05 | 505 | 111 | 11 | M39167 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | INTS6L PGGHG TSC22D3 BAZ1B RAPGEF1 IRF1 FBXO11 FRYL ITGA1 SLFN5 XPO1 GMIP DPP8 TRIP12 DDX5 EFR3A NUP210 PRKCB HERPUD2 | 1.55e-05 | 1492 | 111 | 19 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | CPNE2 LAPTM4A PGGHG TSC22D3 PKP4 IRF1 ACTN1 ITGA1 GALNT18 SH3BP4 CHST15 FRMD6 PTPRM PDE7B | 2.37e-05 | 888 | 111 | 14 | M39049 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.98e-05 | 466 | 111 | 10 | M13522 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN | 4.33e-05 | 91 | 111 | 5 | M2154 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.58e-05 | 303 | 111 | 8 | M39040 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | 4.69e-05 | 304 | 111 | 8 | M45711 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 5.13e-05 | 226 | 111 | 7 | M11238 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PKP4 BAZ1B FRYL XPO1 TRIP12 PTK2 EFR3A DST DLC1 PTPRM NFIB SEC24B ARID5B | 6.90e-05 | 856 | 111 | 13 | M4500 |
| Coexpression | HAY_BONE_MARROW_STROMAL | TBX15 THSD4 LAPTM4A FMOD ITGA1 TBX18 DLC1 FRMD6 PTPRM NFIB GLI3 PDZRN4 | 1.01e-04 | 767 | 111 | 12 | M39209 |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP | 1.03e-04 | 175 | 111 | 6 | M6684 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 1.20e-04 | 180 | 111 | 6 | M8906 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | FMOD ACTN1 SEC31A ITGA1 TGFB3 PIEZO2 DLC1 CHST15 FRMD6 ARID5B PLAU | 1.51e-04 | 681 | 111 | 11 | M39175 |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 1.86e-04 | 195 | 111 | 6 | M8151 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 1.97e-04 | 197 | 111 | 6 | M8611 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH1_UP | 1.97e-04 | 197 | 111 | 6 | M5532 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN | 2.02e-04 | 198 | 111 | 6 | M6224 | |
| Coexpression | GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN | 2.10e-04 | 127 | 111 | 5 | M441 | |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP | 2.13e-04 | 200 | 111 | 6 | M7990 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 2.13e-04 | 200 | 111 | 6 | M6609 | |
| Coexpression | GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN | 2.13e-04 | 200 | 111 | 6 | M6574 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN | 2.13e-04 | 200 | 111 | 6 | M6567 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN | 2.13e-04 | 200 | 111 | 6 | M9961 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 2.13e-04 | 200 | 111 | 6 | M9262 | |
| Coexpression | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP | 2.25e-04 | 70 | 111 | 4 | M6897 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.42e-04 | 131 | 111 | 5 | M39232 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.54e-04 | 493 | 111 | 9 | M19391 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | THSD4 CPNE2 APLP2 ITGA1 GALNT18 TGFB3 DLC1 PTPRM NFIB SEMA6A PDE7B | 1.77e-05 | 439 | 110 | 11 | GSM777059_500 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | CPNE2 IRF1 APLP2 FRYL ITGA1 SLFN5 DPP8 HPS3 PIEZO2 DLC1 CHST15 ARID5B PLAU PLCL1 PDE7B | 4.36e-05 | 872 | 110 | 15 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.38e-05 | 123 | 110 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | INTS6L IRF1 SLFN5 GALNT18 PTK2 PIEZO2 DLC1 CHST15 PTPRM NFIB PLAU SEMA6A PLCL1 PDE7B | 9.98e-05 | 831 | 110 | 14 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | CPNE2 APLP2 ITGA1 GALNT18 TGFB3 DLC1 PTPRM NFIB SEMA6A PDE7B | 1.17e-04 | 450 | 110 | 10 | GSM777063_500 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | CPNE2 IRF1 APLP2 ITGA1 SLFN5 DPP8 GALNT18 PIEZO2 DLC1 CHST15 PTPRM NFIB SEMA6A PDE7B | 1.27e-04 | 850 | 110 | 14 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.28e-04 | 455 | 110 | 10 | GSM777055_500 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | LAPTM4A IMPDH1 APLP2 ITGA1 GALNT18 PIEZO2 DLC1 NFIB SCN7A SEMA6A | 8.12e-11 | 194 | 114 | 10 | 6115c20ffe414378508f3879e67815b6062341a7 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.44e-11 | 197 | 114 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.24e-09 | 185 | 114 | 9 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.24e-09 | 185 | 114 | 9 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PND14-Endothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-09 | 194 | 114 | 9 | cee89d4340738f09d07a159cd6aeee4300776988 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-09 | 194 | 114 | 9 | 32962060d80f3edffbe9f0ecad3000c3a9817865 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-09 | 194 | 114 | 9 | 6317e9cdf96eb020f84d50bf41f803db5c9c04a0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-09 | 194 | 114 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-09 | 194 | 114 | 9 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-09 | 194 | 114 | 9 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-09 | 194 | 114 | 9 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.05e-09 | 196 | 114 | 9 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.15e-09 | 197 | 114 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-09 | 198 | 114 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.35e-09 | 199 | 114 | 9 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.45e-09 | 200 | 114 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.45e-09 | 200 | 114 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.45e-09 | 200 | 114 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | P15|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-08 | 171 | 114 | 8 | 155e7abd52b84d16146001f6ca49ca0c2294a823 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.66e-08 | 185 | 114 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.90e-08 | 187 | 114 | 8 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-08 | 189 | 114 | 8 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-08 | 189 | 114 | 8 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-08 | 189 | 114 | 8 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-08 | 192 | 114 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 3.55e-08 | 192 | 114 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-08 | 193 | 114 | 8 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-08 | 193 | 114 | 8 | ce5c3ab79900aa6f394c894267340167009c6149 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-08 | 193 | 114 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-08 | 193 | 114 | 8 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-08 | 193 | 114 | 8 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-08 | 194 | 114 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-08 | 194 | 114 | 8 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-08 | 194 | 114 | 8 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.85e-08 | 194 | 114 | 8 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.01e-08 | 195 | 114 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.17e-08 | 196 | 114 | 8 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.17e-08 | 196 | 114 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.34e-08 | 197 | 114 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.34e-08 | 197 | 114 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-08 | 198 | 114 | 8 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-07 | 167 | 114 | 7 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 4.03e-07 | 179 | 114 | 7 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 4.35e-07 | 181 | 114 | 7 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-07 | 182 | 114 | 7 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-07 | 183 | 114 | 7 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.04e-07 | 185 | 114 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.22e-07 | 186 | 114 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.22e-07 | 186 | 114 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.41e-07 | 187 | 114 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-07 | 187 | 114 | 7 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.41e-07 | 187 | 114 | 7 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.41e-07 | 187 | 114 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-07 | 188 | 114 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.61e-07 | 188 | 114 | 7 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-07 | 188 | 114 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 5.82e-07 | 189 | 114 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 6.03e-07 | 190 | 114 | 7 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-07 | 190 | 114 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-07 | 190 | 114 | 7 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.03e-07 | 190 | 114 | 7 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.03e-07 | 190 | 114 | 7 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-07 | 190 | 114 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-07 | 190 | 114 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.03e-07 | 190 | 114 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-07 | 190 | 114 | 7 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-07 | 190 | 114 | 7 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-07 | 190 | 114 | 7 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.03e-07 | 190 | 114 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-07 | 190 | 114 | 7 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-07 | 191 | 114 | 7 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-07 | 191 | 114 | 7 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-07 | 191 | 114 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.24e-07 | 191 | 114 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-07 | 192 | 114 | 7 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-07 | 192 | 114 | 7 | 6b69bb8fab9b470850eba1a070a500435ec233cd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.69e-07 | 193 | 114 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-07 | 193 | 114 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-07 | 193 | 114 | 7 | 1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-07 | 193 | 114 | 7 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | PND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-07 | 193 | 114 | 7 | f3c743b340fc588bc8effd375b12e2c7cbfa49d2 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.69e-07 | 193 | 114 | 7 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.93e-07 | 194 | 114 | 7 | cf7f232827945fbafd2c298c08a799ab916c2472 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.93e-07 | 194 | 114 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| Drug | CID6451162 | 4.11e-08 | 8 | 114 | 4 | CID006451162 | |
| Drug | cathepsin C substrate | 2.42e-06 | 6 | 114 | 3 | CID003508173 | |
| Drug | MK-251 | 2.42e-06 | 6 | 114 | 3 | CID000176160 | |
| Drug | diphenyl phosphonate | 3.34e-06 | 21 | 114 | 4 | CID006327546 | |
| Drug | Epostatin | 4.22e-06 | 7 | 114 | 3 | CID006449105 | |
| Drug | o-Py | 4.22e-06 | 7 | 114 | 3 | CID009942336 | |
| Drug | imidazolelactate | 6.72e-06 | 8 | 114 | 3 | CID000000793 | |
| Drug | Gly-pro-na | 1.00e-05 | 9 | 114 | 3 | CID000194319 | |
| Drug | Appna | 1.00e-05 | 9 | 114 | 3 | CID006453929 | |
| Drug | NSC-334212 | 1.00e-05 | 9 | 114 | 3 | CID000333414 | |
| Drug | Hxp | 1.43e-05 | 10 | 114 | 3 | CID000449159 | |
| Drug | X1043 | 1.43e-05 | 10 | 114 | 3 | CID011235728 | |
| Drug | histidinoalanine | 1.48e-05 | 30 | 114 | 4 | CID000444509 | |
| Drug | crinosterol | 1.96e-05 | 11 | 114 | 3 | CID000086576 | |
| Drug | UAMC00132 | 2.49e-05 | 2 | 114 | 2 | ctd:C524159 | |
| Drug | Gly-pro-mca | 3.37e-05 | 13 | 114 | 3 | CID000125640 | |
| Drug | sampatrilat | 3.37e-05 | 13 | 114 | 3 | CID006324648 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.85e-05 | 183 | 114 | 7 | 7498_DN | |
| Drug | AC1MHZPD | 4.27e-05 | 14 | 114 | 3 | CID003035635 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 4.73e-05 | 189 | 114 | 7 | 4450_UP | |
| Drug | AC1L322F | 5.32e-05 | 15 | 114 | 3 | CID000133040 | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 6.15e-05 | 197 | 114 | 7 | 2148_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 6.15e-05 | 197 | 114 | 7 | 6666_UP | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 5496_DN | |
| Drug | sitagliptin | 6.93e-05 | 44 | 114 | 4 | CID004369359 | |
| Drug | SureCN3749646 | 7.43e-05 | 3 | 114 | 2 | CID011530920 | |
| Drug | SureCN3745540 | 7.43e-05 | 3 | 114 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 7.43e-05 | 3 | 114 | 2 | CID011974435 | |
| Drug | ABT-279 | 7.43e-05 | 3 | 114 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 39 | 7.43e-05 | 3 | 114 | 2 | CID011117606 | |
| Drug | Cyanopyrrolidine 38 | 7.43e-05 | 3 | 114 | 2 | CID010932707 | |
| Drug | SureCN3748611 | 7.43e-05 | 3 | 114 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 7.43e-05 | 3 | 114 | 2 | CID000193559 | |
| Drug | I11-0029 | 7.58e-05 | 45 | 114 | 4 | CID005251896 | |
| Drug | CAS 68-19-9 | 9.12e-05 | 145 | 114 | 6 | CID000002891 | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 2.24e-07 | 4 | 114 | 3 | DOID:0050679 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.72e-05 | 139 | 114 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | waist-hip ratio | TBX15 THSD4 PAPPA2 C2orf69 CPAMD8 TRIP12 TBX18 DLC1 GLI3 ARID5B EFR3B DLAT RGS17 OLFM2 PDZRN4 | 7.70e-05 | 1226 | 114 | 15 | EFO_0004343 |
| Disease | adverse effect, response to xenobiotic stimulus | 8.16e-05 | 59 | 114 | 4 | EFO_0009658, GO_0009410 | |
| Disease | respiratory failure, COVID-19 | 1.91e-04 | 29 | 114 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | diastolic blood pressure, systolic blood pressure | TBX15 CACNA1C FBXO11 TBX18 PIEZO2 DLC1 ARID5B OLFM2 HERPUD2 IL2RA | 2.79e-04 | 670 | 114 | 10 | EFO_0006335, EFO_0006336 |
| Disease | nitric oxide exhalation measurement | 4.29e-04 | 38 | 114 | 3 | EFO_0005536 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 5.00e-04 | 40 | 114 | 3 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | hippocampal CA4 volume | 5.38e-04 | 41 | 114 | 3 | EFO_0009396 | |
| Disease | rectum cancer | 5.78e-04 | 42 | 114 | 3 | EFO_1000657 | |
| Disease | cancer (implicated_via_orthology) | 6.24e-04 | 268 | 114 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | vitamin B6 measurement | 6.52e-04 | 10 | 114 | 2 | EFO_0004621 | |
| Disease | asthma | 6.78e-04 | 751 | 114 | 10 | MONDO_0004979 | |
| Disease | peak expiratory flow | 7.19e-04 | 498 | 114 | 8 | EFO_0009718 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 7.95e-04 | 11 | 114 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | lower face morphology measurement | 8.60e-04 | 109 | 114 | 4 | EFO_0010948 | |
| Disease | lymphocyte measurement | 1.12e-03 | 117 | 114 | 4 | EFO_0803546 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.12e-03 | 13 | 114 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | acne | 1.43e-03 | 125 | 114 | 4 | EFO_0003894 | |
| Disease | ankle injury | 1.56e-03 | 59 | 114 | 3 | EFO_1002021 | |
| Disease | Colorectal Carcinoma | 1.64e-03 | 702 | 114 | 9 | C0009402 | |
| Disease | Hallux valgus | 1.64e-03 | 60 | 114 | 3 | HP_0001822 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 1.64e-03 | 60 | 114 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | age-related hearing impairment | 1.65e-03 | 324 | 114 | 6 | EFO_0005782 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.88e-03 | 63 | 114 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | protein C measurement | 1.94e-03 | 17 | 114 | 2 | EFO_0004633 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 1.97e-03 | 64 | 114 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.97e-03 | 64 | 114 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | ascending aortic diameter | 2.16e-03 | 140 | 114 | 4 | EFO_0021787 | |
| Disease | Usual Interstitial Pneumonia | 2.42e-03 | 19 | 114 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.42e-03 | 19 | 114 | 2 | C4721508 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.42e-03 | 19 | 114 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.69e-03 | 20 | 114 | 2 | C4721952 | |
| Disease | FEV/FEC ratio | THSD4 IRF1 ITGA1 NEB PTK2 DDX5 DST DLC1 PTPRM PLAU PLCL1 MYO15A | 2.85e-03 | 1228 | 114 | 12 | EFO_0004713 |
| Disease | Idiopathic Pulmonary Fibrosis | 2.96e-03 | 21 | 114 | 2 | C1800706 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 3.22e-03 | 76 | 114 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 3.55e-03 | 23 | 114 | 2 | MONDO_0015335 | |
| Disease | asthma, allergic disease | 3.59e-03 | 79 | 114 | 3 | MONDO_0004979, MONDO_0005271 | |
| Disease | age of onset of asthma | 3.59e-03 | 79 | 114 | 3 | OBA_2001001 | |
| Disease | intraocular pressure measurement | 3.68e-03 | 509 | 114 | 7 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPPMQYYNSQGDATH | 1066 | Q99569 | |
| DPLQQAYAGMQHYTA | 316 | Q5SZQ8 | |
| LGHYAVAQMQTQCPY | 196 | A6NM45 | |
| SLHYINPMGTNEYLS | 326 | Q96FN4 | |
| TYHVNMAGTNPYTTI | 581 | P12814 | |
| QNYHEIMTRHPENYQ | 111 | Q8N8R5 | |
| RYHGLSGLVQYQMAQ | 351 | Q96QU6 | |
| MLQHLQPTAENAYEY | 96 | Q16611 | |
| YYDVITHPMDFQTVQ | 1376 | Q9UIG0 | |
| QATYHQVYAPSAITM | 251 | Q8N9W6 | |
| FQQGYSLLHQLDPYM | 201 | Q96P50 | |
| PIYLGAAQHMVQYFT | 291 | Q9H221 | |
| AAQHMVQYFTAIGYP | 296 | Q9H221 | |
| YHTYPLRMTNNQGIL | 336 | A6NGH8 | |
| SYYHVMPKQNSTLVG | 1121 | Q6PL18 | |
| HLIKAGVNYTMQVYP | 741 | Q8N608 | |
| GVNYTMQVYPDEGHN | 746 | Q8N608 | |
| GHAQYQSVPVYEMKF | 801 | Q14156 | |
| LQHSGNQSSIMYPTY | 216 | Q9NRE1 | |
| ANIPAHARHYQSYMQ | 841 | Q6ZMN7 | |
| HNQYSHISMLDYNPR | 411 | O95897 | |
| SQPYYHDMNSGVNLQ | 246 | O00712 | |
| VVNQVYGYFVLGHPM | 111 | P0DN78 | |
| TNSQLQTPMYFFLGH | 51 | Q6IEU7 | |
| PNPHMYEDAQLQIYT | 166 | Q9UGC6 | |
| LHSVPVAQMGNYQEY | 546 | Q5JSJ4 | |
| HSSYTVPGYMQDLEV | 161 | P10914 | |
| VVNQVYGYFVLGHPM | 111 | P0DN77 | |
| HLNKMQNHGYENPTY | 741 | Q06481 | |
| NPAYDVYLMVGTSIH | 246 | Q8TEM1 | |
| LEQLYMEHNNVYTVP | 246 | Q06828 | |
| YQTKYEEMQVTAGQH | 356 | Q9NSB2 | |
| EYYHQMALLTGQRSP | 236 | P10071 | |
| INVEIGNPSYNMYEV | 4486 | Q9NZR2 | |
| YLNSMHSLVNSVPYE | 276 | O43365 | |
| NELYVTMHYNQVLPD | 3306 | Q9UKN7 | |
| QQQSHMPLQYIYTLF | 141 | Q9P107 | |
| MISSNPQVQYHNDKY | 2301 | Q03001 | |
| SMPAVNIQYEVIGNY | 56 | Q15012 | |
| YQYLNGVNPVMLHCI | 276 | Q9BYJ1 | |
| IYPYEMFQSGANHVQ | 161 | Q9BY66 | |
| YDSTQQYGSNVPNMH | 571 | P17844 | |
| NEEYYQLLMSSEGHP | 151 | O15055 | |
| MIPYQIGDVFISHSQ | 66 | Q9NQP4 | |
| QTIPHYYLSIDVNMG | 441 | P10515 | |
| FVIITQQSLHEPMYY | 56 | A6NGY5 | |
| MVQEDYHSQNPYHNA | 161 | Q9NP56 | |
| YGQPQNHSIPVYEMK | 796 | Q9Y2G0 | |
| QTSYHDPIMGNKYAA | 1896 | O94915 | |
| YSLSPVYESGQQMFQ | 121 | Q9Y337 | |
| EYVNGGDLMYHIQQV | 421 | P05771 | |
| MSPDEYHSGVNNSVY | 426 | Q32M88 | |
| QPRYNHTGQVIIYRM | 456 | P56199 | |
| YNYAEQTMSHLPQVQ | 241 | Q9BQ04 | |
| HLIQNNMPGNYVFSY | 131 | P22557 | |
| SQGNSVYQIAMVHYI | 276 | P20839 | |
| VVNQVYGYFVLGHPM | 111 | P04001 | |
| FTDVEVTPGQMYQYQ | 1076 | Q9BXP8 | |
| VTPGQMYQYQVLAEA | 1081 | Q9BXP8 | |
| SYIYNTVQQHKPEQG | 551 | Q9Y2V7 | |
| PMIIHFRVQYYVENG | 106 | Q96NE9 | |
| TQQVEQDMFAHPYQY | 246 | Q01780 | |
| TRMYIPEENHQGSNY | 6 | Q13936 | |
| NDIYNHMYSGVQIRT | 656 | Q86XK2 | |
| YTERYMDVPENNQHG | 766 | Q86TI2 | |
| NESTYYMEGNLGHPV | 206 | Q9UBR1 | |
| LPHVYMRKQSQVYGE | 61 | Q6VVX0 | |
| INMTVNGVGYYSHEV | 266 | Q8IZJ3 | |
| YTERYMGHPDQNEQG | 791 | Q6V1X1 | |
| AQMDQNPGYYHQLLQ | 86 | Q5TC63 | |
| MTPQNVYYTSSQQIH | 501 | Q6P9A2 | |
| YHSMPTYLNSLNNAI | 1736 | Q9BZC7 | |
| TMGPSQHVYAYSQEM | 511 | Q99062 | |
| QHVYAYSQEMAPSHA | 516 | Q99062 | |
| HFVVGQMVYYQCVQG | 141 | P01589 | |
| TDQAQSHQFPYVMQG | 151 | Q9BSE4 | |
| HEGLCNMYNIQAYPT | 511 | Q8IXB1 | |
| YQTLNEAIMHQYPNF | 391 | Q6SJ93 | |
| MQVPSGYGLHHQNYI | 51 | O95487 | |
| HYEVVQYLLSNGQMD | 851 | Q9H9B1 | |
| NHYIATQGPMQETIY | 966 | P28827 | |
| VLSAYNQQGDPTMYE | 201 | Q15542 | |
| QQPHYYGSEVTTKML | 346 | P00749 | |
| HNTTEMGYIPSSYVQ | 96 | Q9P0V3 | |
| YQTPMEVAVYQLHNF | 6 | Q99576 | |
| MVQLYNLHPFGSQQV | 1 | Q969F9 | |
| SSTQMVVHEIRNYPY | 201 | Q6ZSG1 | |
| PMLNIYQEFVRNHQY | 331 | O14827 | |
| MVQTNHYQVSGYPGS | 736 | Q05397 | |
| LGSSHYQYQRMAPQA | 246 | O15353 | |
| YQYQRMAPQASTDGH | 251 | O15353 | |
| TNHGQFQAMATRPYY | 346 | O75603 | |
| TGLDPHQQYYIAMDI | 151 | Q96SF7 | |
| HQQYYIAMDIVPVDN | 156 | Q96SF7 | |
| YIQGQDMHPMVAEYQ | 136 | Q96JS3 | |
| IYQYVQNSMAPHPAR | 1411 | Q96QB1 | |
| MNENHGLNYTPLLYS | 666 | Q14865 | |
| HQSSVNNISYMKDYP | 136 | Q7LFX5 | |
| LEKTGHMPNYQFVYQ | 806 | Q8TCY9 | |
| HMPNYQFVYQNLHDV | 811 | Q8TCY9 | |
| VAQDMTQPLSHYYIN | 396 | Q15111 | |
| QPQQVHTFYEAVGYM | 626 | O14980 | |
| PSMFYQTPQNEHIYQ | 566 | Q13905 | |
| DVMEDLYNYINPHNG | 96 | P23921 | |
| HDPMYQYRVDTGNFQ | 441 | Q9P2C4 | |
| ISGLDPHQQYYIAMD | 176 | O95935 | |
| TQQGYQHEYVDQPKM | 821 | Q9H2E6 | |
| HYKVMSVGQNYTIEL | 226 | Q9ULZ2 | |
| NYPVNNMVTGYISID | 166 | Q8NHR7 | |
| TSGYLAYHVQNEINM | 196 | Q8NHR7 | |
| ENMEAHNGTPLTNYY | 131 | P20061 | |
| NVPTRESIHMYYQNH | 1696 | Q9H5I5 | |
| MVAFYQELHTPTQGQ | 76 | Q8IV45 | |
| MVTNPHYQGQVSFLD | 76 | Q96A28 | |
| AVSSPMSQHQSYIQY | 1331 | Q9ULD9 | |
| AVNIQPHFEVNIYMY | 1156 | Q01118 | |
| VMVENYNHLVSLGYQ | 36 | Q8N883 | |
| VHYEYVIMGTNAISP | 521 | Q6ZMP0 | |
| HQMPRVQTQQYYPHG | 821 | O94979 | |
| HLLPYNMTVYQAVRQ | 1351 | Q14669 | |
| LQIYPESYNFMTPQH | 511 | Q08AF3 | |
| VMTHVPYQVLALYNS | 61 | P10600 | |
| QTPYLHLSAMQEGDY | 581 | Q5VV43 | |
| ANYRNVIHTYNMLPD | 1891 | P20929 |